Exploring the Efficacy and Usability of the My Autism Passport (MAP).

N/A

Waitlist Available

Led By Elizabeth Young, MD

Research Sponsored by Unity Health Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Families of children between 0-6 years of age, who have been diagnosed with autism spectrum disorder within the past month from five sites within the Greater Toronto Area that conduct developmental assessments will be eligible to participate in the study.

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is assessing the feasibility of a mobile application called My Autism Passport, which helps families of children with autism spectrum disorder keep track of publicly-funded ASD services.

Eligible Conditions

Autism Spectrum Disorder
Autism

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Number of services contacted at 12 months

Number of services contacted at 18 months

Number of services contacted at 6 months

Secondary study objectives

Parent Empowerment and Efficacy Measure at 12 months

Parent Empowerment and Efficacy Measure at 18 months

Parent Empowerment and Efficacy Measure at 6 months

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention- My Autism Passport AppExperimental Treatment1 Intervention

Families will be given the application to upload to their mobile device and will be provided information on how to use the App by the research team. The contact information for a member of the research team who will be able to provide technical support will be available on the consent form. Families will use the mobile application for a total of 18 months. Given that this is a pragmatic trial of a tool that tracks services, it also may be used to communicate service access to other providers.

Group II: Control-Standard of careActive Control1 Intervention

Families in the control group will continue with standard of clinical care, and receive any of the usual supports their clinic and region provides, including access to physicians, service navigators, social workers, nurses, etc.

0 / 1Eligibility criteria met